vs
California BanCorp \ CA（BCAL）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是California BanCorp \ CA的1.5倍（$69.8M vs $45.9M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 35.8%，领先348.3%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 0.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 44.7%）
太平洋第一控股是依据美国1956年银行控股公司法案成立的美国银行控股集团，总部位于加利福尼亚州欧文市。集团核心业务围绕旗下太平洋第一银行展开，为个人、企业及专业人士提供各类金融服务，目前在加州、亚利桑那州、内华达州和华盛顿州开设了多家网点。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
BCAL vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.5倍
$45.9M
营收增速更快
RIGL
高出20.4%
0.8%
净利率更高
RIGL
高出348.3%
35.8%
两年增速更快
RIGL
近两年复合增速
44.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.9M | $69.8M |
| 净利润 | $16.4M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 48.8% | 33.2% |
| 净利率 | 35.8% | 384.0% |
| 营收同比 | 0.8% | 21.2% |
| 净利润同比 | -2.1% | 1769.2% |
| 每股收益（稀释后） | $0.50 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCALRIGL
| Q4 25 | $45.9M | $69.8M | ||
| Q3 25 | $45.2M | $69.5M | ||
| Q2 25 | $44.3M | $101.7M | ||
| Q1 25 | $44.8M | $53.3M | ||
| Q4 24 | $45.5M | $57.6M | ||
| Q3 24 | $38.1M | $55.3M | ||
| Q2 24 | $22.2M | $36.8M | ||
| Q1 24 | $21.9M | $29.5M |
净利润BCALRIGL
| Q4 25 | $16.4M | $268.1M | ||
| Q3 25 | $15.7M | $27.9M | ||
| Q2 25 | $14.1M | $59.6M | ||
| Q1 25 | $16.9M | $11.4M | ||
| Q4 24 | $16.8M | $14.3M | ||
| Q3 24 | $-16.5M | $12.4M | ||
| Q2 24 | $190.0K | $-1.0M | ||
| Q1 24 | $4.9M | $-8.2M |
毛利率BCALRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率BCALRIGL
| Q4 25 | 48.8% | 33.2% | ||
| Q3 25 | 48.3% | 40.9% | ||
| Q2 25 | 45.3% | 60.1% | ||
| Q1 25 | 52.8% | 23.9% | ||
| Q4 24 | 52.2% | 28.9% | ||
| Q3 24 | -59.1% | 25.4% | ||
| Q2 24 | 1.3% | 1.2% | ||
| Q1 24 | 33.1% | -23.6% |
净利率BCALRIGL
| Q4 25 | 35.8% | 384.0% | ||
| Q3 25 | 34.7% | 40.2% | ||
| Q2 25 | 31.8% | 58.6% | ||
| Q1 25 | 37.6% | 21.5% | ||
| Q4 24 | 37.7% | 24.9% | ||
| Q3 24 | -43.2% | 22.5% | ||
| Q2 24 | 0.9% | -2.8% | ||
| Q1 24 | 22.5% | -27.9% |
每股收益（稀释后）BCALRIGL
| Q4 25 | $0.50 | $14.11 | ||
| Q3 25 | $0.48 | $1.46 | ||
| Q2 25 | $0.43 | $3.28 | ||
| Q1 25 | $0.52 | $0.63 | ||
| Q4 24 | $0.54 | $0.82 | ||
| Q3 24 | $-0.59 | $0.70 | ||
| Q2 24 | $0.01 | $-0.06 | ||
| Q1 24 | $0.26 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $399.9M | $155.0M |
| 总债务越低越好 | $33.8M | $52.5M |
| 股东权益账面价值 | $576.6M | $391.5M |
| 总资产 | $4.0B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.06× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资BCALRIGL
| Q4 25 | $399.9M | $155.0M | ||
| Q3 25 | $559.2M | $137.1M | ||
| Q2 25 | $430.1M | $108.4M | ||
| Q1 25 | $439.2M | $77.1M | ||
| Q4 24 | $388.2M | $77.3M | ||
| Q3 24 | $614.4M | $61.1M | ||
| Q2 24 | $104.7M | $49.1M | ||
| Q1 24 | $86.5M | $49.5M |
总债务BCALRIGL
| Q4 25 | $33.8M | $52.5M | ||
| Q3 25 | $33.4M | $60.0M | ||
| Q2 25 | $52.9M | $60.0M | ||
| Q1 25 | $70.3M | $60.0M | ||
| Q4 24 | $69.7M | $60.0M | ||
| Q3 24 | $69.1M | $60.0M | ||
| Q2 24 | $42.9M | $60.0M | ||
| Q1 24 | $44.9M | $60.0M |
股东权益BCALRIGL
| Q4 25 | $576.6M | $391.5M | ||
| Q3 25 | $564.7M | $117.6M | ||
| Q2 25 | $547.6M | $81.9M | ||
| Q1 25 | $531.4M | $18.6M | ||
| Q4 24 | $511.8M | $3.3M | ||
| Q3 24 | $498.1M | $-14.6M | ||
| Q2 24 | $293.2M | $-29.9M | ||
| Q1 24 | $292.5M | $-31.7M |
总资产BCALRIGL
| Q4 25 | $4.0B | $513.6M | ||
| Q3 25 | $4.1B | $242.5M | ||
| Q2 25 | $4.0B | $206.7M | ||
| Q1 25 | $4.0B | $176.0M | ||
| Q4 24 | $4.0B | $164.0M | ||
| Q3 24 | $4.4B | $139.4M | ||
| Q2 24 | $2.3B | $128.4M | ||
| Q1 24 | $2.3B | $126.5M |
负债/权益比BCALRIGL
| Q4 25 | 0.06× | 0.13× | ||
| Q3 25 | 0.06× | 0.51× | ||
| Q2 25 | 0.10× | 0.73× | ||
| Q1 25 | 0.13× | 3.23× | ||
| Q4 24 | 0.14× | 18.25× | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.15× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $56.9M | — |
| 自由现金流率自由现金流/营收 | 124.1% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | 3.49× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $93.1M | — |
8季度趋势，按日历期对齐
经营现金流BCALRIGL
| Q4 25 | $57.3M | $22.0M | ||
| Q3 25 | $16.0M | $24.0M | ||
| Q2 25 | $13.4M | $30.5M | ||
| Q1 25 | $7.0M | $-893.0K | ||
| Q4 24 | $50.3M | $14.5M | ||
| Q3 24 | $18.3M | $21.7M | ||
| Q2 24 | $309.0K | $302.0K | ||
| Q1 24 | $8.1M | $-5.0M |
自由现金流BCALRIGL
| Q4 25 | $56.9M | — | ||
| Q3 25 | $15.9M | — | ||
| Q2 25 | $13.4M | — | ||
| Q1 25 | $6.9M | — | ||
| Q4 24 | $49.7M | — | ||
| Q3 24 | $18.1M | — | ||
| Q2 24 | $171.0K | — | ||
| Q1 24 | $8.0M | — |
自由现金流率BCALRIGL
| Q4 25 | 124.1% | — | ||
| Q3 25 | 35.1% | — | ||
| Q2 25 | 30.2% | — | ||
| Q1 25 | 15.3% | — | ||
| Q4 24 | 109.2% | — | ||
| Q3 24 | 47.5% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 36.4% | — |
资本支出强度BCALRIGL
| Q4 25 | 0.8% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.4% | — |
现金转化率BCALRIGL
| Q4 25 | 3.49× | 0.08× | ||
| Q3 25 | 1.02× | 0.86× | ||
| Q2 25 | 0.95× | 0.51× | ||
| Q1 25 | 0.41× | -0.08× | ||
| Q4 24 | 3.00× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | 1.63× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
